Carbiotix launches cost-effective service to study gut health
Oct 26, 2018
Carbiotix, an award-winning personalized nutrition company focused on consumer gut health
solutions and microbiome therapeutics, has launched StudyGut, a new cost-effective service to
study the long-term impacts of new and existing active ingredients on the gut health of large
"The launch of the StudyGut service is a direct result of our own development activities and
a planned study of 600 participants across four indications to start in November of 2018. After
only two weeks of recruiting, close to 4,000 individuals applied to our study, which suggests
the platform is very effective and could be used by others to recruit study subjects and carry
out explorative studies", says CEO Kristofer Cook.
"Based on discussions with different ingredient companies, we believe that there is a demand
for an end-to-end service for carrying out explorative gut health studies of new or existing
active ingredients across large populations, under real-life conditions and at a fraction of
the cost compared to traditional pre-clinical and clinical studies. Validating active ingredient
efficacy as early as possible under real-life conditions is a very cost effective screening
method given the cost of downstream clinical studies", says CTO Peter Falck.